# CMPA-GO Study: Growth and Safety Outcomes in Infants With CMPA Fed a Novel Extensively Hydrolyzed Formula

> **NCT06830681** · NA · TERMINATED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 4 (actual)

## Conditions studied

- Cow Milk Protein Allergy

## Interventions

- **DIETARY_SUPPLEMENT:** New generation eHF
- **DIETARY_SUPPLEMENT:** Commercial eHF

## Key facts

- **NCT ID:** NCT06830681
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-01-07
- **Primary completion:** 2025-05-23
- **Final completion:** 2025-06-23
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Business decision/strategic reason
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06830681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06830681, "CMPA-GO Study: Growth and Safety Outcomes in Infants With CMPA Fed a Novel Extensively Hydrolyzed Formula". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06830681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*